Literature DB >> 2965794

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

D Sun1, Y Qin, J Chluba, J T Epplen, H Wekerle.   

Abstract

Down-regulatory phenomena have been described in several experimental models of tissue-specific, T-cell-mediated autoimmunity. For example, resistance to active induction of experimental autoimmune encephalomyelitis (EAE) can be induced by pretreating animals with non-pathogenic inocula of autoantigen or effector cells. Moreover, animals that have recovered from one EAE episode are resistant to subsequent induction of EAE. In some models, resistance to EAE has been transferred with immune cells to naive recipients. These experiments, which were based on transfers of unseparated immune cell populations, are difficult to interpret. Immune suppression circuits are known to be complex and involve various distinct cellular subsets. To further complicate the issue, resistance to EAE can be transferred not only by suppressor cells, but also by encephalitogenic effector cells injected in 'subclinical' doses. We describe now the isolation of homogeneous T lymphocyte lines from the spleens of Lewis rats that had recovered from T-cell-mediated EAE (tEAE) caused by the MBP-specific T cell line S1. These spleen-derived T line cells express the CD8 phenotype and specifically respond to determinants on the inducing S1 line, but not to the autoantigen MBP. Furthermore, the anti-S1 cells selectively lyse the encephalitogenic S1 T line in vitro and efficiently neutralize their encephalitogenic capacity in vivo.

Entities:  

Mesh:

Year:  1988        PMID: 2965794     DOI: 10.1038/332843a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  60 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

2.  Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice.

Authors:  R Bachmann; H P Eugster; K Frei; A Fontana; H Lassmann
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

3.  Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity.

Authors:  Ikuo Tsunoda; Li-Qing Kuang; Robert S Fujinami
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

Review 5.  Immunoregulation: studies of physiological and therapeutic autoreactivity by T cell vaccination.

Authors:  A W Lohse; I R Cohen
Journal:  Springer Semin Immunopathol       Date:  1992

Review 6.  What future for therapeutic prevention of type 1 (insulin-dependent) diabetes mellitus?

Authors:  P Pozzilli; A Signore; D Andreani
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

7.  Antiviral CD8⁺ T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice.

Authors:  Jane E Libbey; Matthew F Cusick; Ikuo Tsunoda; Robert S Fujinami
Journal:  J Neurovirol       Date:  2012-01-27       Impact factor: 2.643

Review 8.  Homeostatic control of immunity by TCR peptide-specific Tregs.

Authors:  Vipin Kumar
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

9.  Comeback kids: CD8(+) suppressor T cells are back in the game.

Authors:  Luc Van Kaer
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

10.  Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.

Authors:  Vily Panoutsakopoulou; Katharina M Huster; Nami McCarty; Evan Feinberg; Rijian Wang; Kai W Wucherpfennig; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.